Group A Streptococcal rofA Gene Is Involved in the Control of Several Virulence Genes and Eukaryotic Cell Attachment and Internalization

Generation of a serotype M6 GAS rofA insertional mutant.A fragment of the rofA gene from serotype M6 isolate 2/66 of the GAS strain collection from the Prague WHO reference laboratory was amplified by PCR. The fragment corresponding to positions 31 to 980 of the published M6 rofA sequence (3) was cloned into the plasmid vector pSF152 (32). Integration of the plasmid by single cross-over resulted in disruption of the 1,491-bp rofA gene at bp 798.

Effects of rofA inactivation on prtF1expression and fibronectin binding.Experiments were done to confirm that this mutation of rofA was affecting the protein F1 transcription and fibronectin binding as reported elsewhere (3). Total RNA was prepared according to an established protocol (27) from wild-type bacteria, and the isogenicrofA mutant was grown to mid-log growth phase in a standing culture under a 20% O₂–5% CO₂ atmosphere. AprtF1-specific probe (19) was used for a semiquantitative Northern blot hybridization analysis (Fig.1). The prtF1 message was found to be decreased at least eightfold in the rofA mutant.

• Open in new tab
• Download powerpoint

Fig. 1.

Quantitation of virulence gene mRNAs in a serotype M6 GAS strain (wt) and its isogenic rofA regulator mutant. Total RNA was isolated from both strains grown to mid-log phase, was serially diluted in twofold increments, separated by denaturing gel electrophoresis, and subjected to Northern blot hybridizations with digoxigenin-labeled virulence gene-specific probes. CSPD (Roche Molecular Biochemicals, Mannheim, Germany) and autoradiography were used to detect hybridization. The amounts of total RNA used in the assays were 20 μg (mga and rofA), 10 μg (prtF1, slo, and speB), and 5 μg (emm6, pel-sagA, and speA).

Binding of soluble ¹²⁵I-labeled fibronectin was measured according to the protocol of Kreikemeyer et al. (13) using commercially available matrix proteins (Gibco-BRL, Eggenstein, Germany). For the assays, the two strains were grown to early-log, early-stationary, and stationary growth phases as standing cultures under a 20% O₂–5% CO₂ atmosphere. The results are the average of three independent experiments. By as early as 3 h of growth in the CO₂-enriched atmosphere, therofA mutant bound 30% less fibronectin. In the stationary phase, the fibronectin-binding of the mutant was further reduced to 61% of the wild-type levels (Table 1).

Effects of rofA inactivation on expression of virulence genes and functions.The rofA homologue nrawas found to control the expression of at least a dozen GAS genes and the collagen-binding activity in a serotype M49 GAS strain ((27); Molinari et al., submitted). Our next objective was to determine whether a functional rofA gene has a comparably broad regulatory activity.

Binding experiments with ¹²⁵I-labeled fibrinogen and collagen were performed under conditions similar to those of the fibronectin-binding assays. The mutant exhibited a slightly reduced fibrinogen binding (Table 1). The differences increased from exponential to stationary growth phase. Since protein F1 was demonstrated to bind fibrinogen in addition to fibronectin (12), the decreased fibrinogen binding of therofA mutant could be explained by the reduction inprtF1 gene transcription. Collagen-binding was unaltered in the rofA mutant, indicating that this feature does not depend on a functional rofA gene in serotype M6 strains. Thus, different RALP members are involved in control of GAS binding to distinct matrix proteins (3, 27; this study).

The expression of several known virulence genes was studied in therofA mutant by semiquantitative Northern blot analysis. The genes of the two secreted factors streptolysin O and cysteine protease SpeB appeared to be unaffected by the rofA mutation (Fig.1). As found for nra mutants (Molinari et al., submitted), the expression of the genes encoding the superantigen SpeA and the streptolysin S (Pel-SagA), as well as the global positive regulator Mga, were increased 8- to 32-fold in the mutant (Fig. 1). These results suggest that RALPs such as RofA and Nra are involved in different regulatory circuits. Both act on the speA gene transcription, for which no other regulator has been determined. Moreover, both act on the mga regulator gene transcription, which in turn could affect the expression of the pel-sagAgene expression.

Increased transcription of M6 protein gene (emm6) in therofA mutant as opposed to negligible changes in theemm49 expression in an nra mutant (Molinari et al., submitted) indicated that RALP control of the emm gene expression is possibly indirectly exerted and could be additionally modulated by superimposed serotype-specific regulatory circuits. Granok et al. (6) described a RofA consensus binding box which they located upstream of the rofA sequences in the genomes of serotypes M6 and M1, as well as upstream of the serotype M1clpX stress-induced gene. When an analysis was done on published sequences, the conserved binding box could not be detected in the promoter regions of mga, emm6,pel-sagA, or speA. This finding could indicate that RofA binds to sequences other than the identified binding box or that changes in transcription of all these genes are due to an indirect effect of RofA.

The rofA-specific transcript in the mutant was larger than that of the wild-type strain due to a read-through transcription into the integrated pSF152 plasmid. Such read-through transcription has also been observed in other pSF152-derived mutants (26). The intensity of the rofA-specific band in the mutant's RNA analysis suggested an at least eightfold-less-abundant message in the mutant, thus confirming the positive autoregulatory effect of a functional RofA mutant described by Fogg et al. (2).

Impact of rofA mutation on eukaryotic cell attachment and internalization.In protein F1-expressing GAS strains, this protein was found to play a major role in bacterial interactions with eukaryotic cells. Thus, our rofA mutant was predicted to be less adhesive and invasive than the corresponding wild type.

To test this assumption, adhesion and internalization experiments were performed using bacteria from overnight cultures and HEp-2 cells following the protocol of Molinari et al. (submitted). Adherent and internalized bacteria were quantitated by plate viability counts. The reported results are the average of six independent experiments. For a better comparison, the results were normalized by arbitrarily setting the wild-type adherence as 100% and relating the other viability counts to this value.

The percent adhesion and percent internalization values were 100 and 2.7 ± 1.6 for the wild type and 59.9 ± 33.1 and 0.21 ± 0.20 for the mutant, respectively.

Eukaryotic cell attachment of the rofA mutant was therefore decreased by 40% compared to the parental strain. This reduction correlated well to measurements of decreased fibronectin binding by the mutant, suggesting that the altered matrix protein binding was sufficient to explain the changes in cell adhesion.

In contrast, the internalization rate of the mutant was only 7% of the wild-type value, indicating that superimposed additional mechanisms besides fibronectin-binding influenced the uptake of therofA mutant into HEp-2 cells.

Eukaryotic cell viability in presence of the rofAmutant.A decreased host cell viability could lead to a reduction of bacterial viability counts when using culture media containing antibiotics.

Therefore, the host cell viability in the attachment and internalization assays was controlled by using the fluorescent LIVE/DEAD stain according to the manufacturer's instructions (Molecular Probes/Mobitec, Göttingen, Germany). After 4 h of coincubation, ca. 20 to 30% of the HEp-2 cells showed typical red fluorescence with the DEAD stain in the presence of the mutant, while <5% of the eukaryotic cells did so in the presence of the parental strain (data not shown).

An even stronger reduction in HEp-2 cell viability was recorded in the presence of nra mutant bacteria (Molinari et al., submitted). In both cases, the decreased eukaryotic cell viability could potentially be explained by an overproduction of secreted harmful factors like SpeA or streptolysin S (Pel-SagA) by the mutants.

Conclusion.In this study, we investigated the impact of a mutation in a member of the RALP regulator family, rofA, on virulence gene expression and the concomitant biological behavior of a serotype M6 GAS strain. In agreement with previous publications (3), expression of the protein F1-encodingprtF1 gene and fibronectin binding as well as the truncatedrofA gene was decreased in the mutant, confirming the status of RofA as a positive regulator for these virulence traits. However, a functional rofA gene also appeared to act as a negative regulator for the expression of several other virulence genes. These results agreed with many of those obtained for another RALP member, thenra gene (27). Since the promoters of the controlled genes lack the recently identified RofA binding box (6), it needs to be determined whether RofA regulation is indirect for these virulence genes. Because a functionalrofA decreased the expression of mga, the global positive virulence regulator in the serotype M6 strain (14), rofA could be the superimposed negative regulator, whose presence was recently predicted in a study on Mga functions in a serotype M6 strain (15). Like the homologous Nra regulator (Molinari et al., submitted), RofA influences the host cell viability once the bacteria are internalized into the eukaryotic cells. This property is obviously associated with control mechanisms exceeding the known regulation of protein F1 expression. Since other RALP members have a similar function (Molinari et al., submitted), these regulators could have an important general role in stabilizing the intracellular status of GAS.